Gregory Spurlock
About Gregory E. Spurlock
Independent director of RadNet (RDNT); age 63 (as of March 31, 2025); director since 2021. Former President of Alliance HealthCare Services with decades of operating leadership in outpatient imaging and hospital-based services; currently a Senior Advisor to Global Medical Response. Education: B.S., Virginia Tech. Brings extensive operational, management and industry experience relevant to radiology services and payor/provider dynamics .
Past Roles
| Organization | Role | Tenure/Date | Committees/Impact |
|---|---|---|---|
| Alliance HealthCare Services | President; directed professional, technical and global hospital-based services across 40 centers in 19 states | Retired in 2019 | Led transition from public to privately owned (2017) |
| U.S. Radiosurgery, LLC | Executive leader | Acquisition by Alliance in 2011 | Helped lead through acquisition |
| Tennessee Orthopaedic Alliance (Nashville) | Director | Not disclosed | Practice management leadership |
| Kerlan-Jobe Orthopedic Clinic (Los Angeles) | Executive Director | Not disclosed | Orthopedic clinic operations |
External Roles
| Organization | Role | Dates | Notes |
|---|---|---|---|
| Global Medical Response (KKR portfolio) | Senior Advisor | Current | 38,000+ employees; emergency response services |
| LLR Partners (PE firm) | Senior Advisor | Aug 2019–Aug 2024 | Healthcare-focused private equity |
| CyberKnife Coalition | Board | Not disclosed | Industry advocacy/coalition |
| American Society for Radiation Oncology (ASTRO) | Corporate Advisory Council | Not disclosed | Industry advisory role |
| American Association of Orthopaedic Executives | Board of Directors | Not disclosed | Professional association governance |
Board Governance
| Item | Detail |
|---|---|
| Independence | Determined independent under Nasdaq and SEC rules |
| Committees | Compensation Committee; Nominating & Governance Committee |
| Committee chair roles | None (chairs: Levitt—Compensation; Jacobs—Nominating & Governance) |
| Board leadership | CEO is also Chair; Lead Independent Director: David L. Swartz (chairs executive sessions of independent directors) |
| Meetings in 2024 | Board: 6 meetings; Compensation Committee: 4 meetings (+1 written consent); Nominating & Governance Committee: 0 meetings (+1 written consent) |
| Attendance | Each director attended 100% of applicable Board and committee meetings in 2024 |
| Annual meeting attendance | None of the directors attended the 2024 Annual Meeting of Stockholders (engagement watch item) |
| Related-party review | Nominating & Governance Committee reviews/approves related party transactions >$120,000 |
Fixed Compensation (Director)
| Component | Amount/Detail | Notes |
|---|---|---|
| Annual cash retainer (2024 structure) | $85,000 | Effective Jan 1, 2024 |
| Meeting fees | $1,500 per committee meeting | Applies to committee attendance |
| Committee chair fees | Audit $20,000; Compensation $15,000; Nominating & Governance $10,000 | Not applicable to Spurlock (not a chair) |
| Equity retainer (2024 structure) | $160,000 | Granted annually |
| 2024 actual cash to Spurlock | $87,000 | Fees earned/paid in cash |
| 2024 actual equity to Spurlock | $159,994 | Grant-date fair value |
| 2024 total director pay (Spurlock) | $246,994 | Sum of cash and equity |
Performance Compensation (Director)
| Equity Award | Grant Date | Shares | Valuation Basis | Vesting | Performance Conditions |
|---|---|---|---|---|---|
| Restricted Stock (annual grant) | June 13, 2024 | 2,591 | ~$160,000 based on $61.75 close on June 12, 2024 | Vests at end of director’s term (coincides with next Annual Meeting), subject to continued service | None (time-based vesting only) |
Note: RDNT does not condition non-employee director equity on financial performance metrics; awards are time-based .
Other Directorships & Interlocks
- Public company directorships: No current public company boards disclosed for Spurlock .
- Compensation Committee interlocks: None; RDNT discloses no interlocks among current members (Levitt, Jacobs, Spurlock, Swartz) .
Expertise & Qualifications
- Deep operating experience in outpatient imaging and hospital-based services; prior leadership of a national imaging platform and specialty clinics .
- Board skills matrix highlights governance, financial, operations, human capital, industry knowledge, and risk management across nominees, including Spurlock .
Equity Ownership
| Holder | Shares Beneficially Owned | Ownership % | Breakdown | Pledging/Hedging |
|---|---|---|---|---|
| Gregory E. Spurlock | 2,591 | <1% | All reported as unvested time-based restricted stock; no options reported | RDNT policy prohibits hedging and pledging absent approved exceptions; no pledges disclosed for Spurlock |
Compensation Committee Context (for governance assessment)
- Independent compensation consultant (Pearl Meyer) advises committee; committee determined no conflicts of interest .
- Non-employee director pay maximum per calendar year capped at $500,000 under the Equity Incentive Plan .
- Recent changes: Effective Jan 1, 2024, increased cash retainer to $85,000 and equity retainer to $160,000; elevated chair and lead independent director retainers .
Related-Party / Conflict Review
- RDNT discloses related-party transactions (e.g., BRMG arrangement; HFB Heirs Trust II lease), but none involve Spurlock .
- Nominating & Governance Committee oversees related-party policy and independence determinations .
Say‑on‑Pay & Shareholder Feedback (Committee-relevant)
| Year | Approval (For Votes as % of votes cast, excl. abstain/broker non-votes) |
|---|---|
| 2023 | ~88% |
| 2024 | ~89% |
Governance Assessment
-
Strengths
- Independent director with directly relevant operating expertise for RDNT’s core imaging business .
- Strong attendance: directors achieved 100% attendance for Board and committee meetings in 2024; Spurlock served on two key governance committees (Compensation; Nominating & Governance) composed entirely of independent directors .
- Use of an independent compensation consultant with no identified conflicts; clear clawback policy compliant with Nasdaq/SEC rules (adopted Nov 2023) .
-
Watch items / potential red flags
- No director-specific stock ownership guideline disclosure; executive section explicitly notes no formal NEO ownership requirements (director guidelines not disclosed) .
- No director attendance at the 2024 Annual Meeting of Stockholders (optics/engagement) .
- Board leadership remains combined CEO/Chair (mitigated by an active Lead Independent Director) .
No related-party transactions or pledging by Spurlock were disclosed; beneficial ownership consists solely of unvested director equity awards as of the reporting date .